Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Globe Newswire•12/08/2026•16:01 ET
0
Whiz Insights
Total revenues were $18.5 million for the second quarter of 2026, reflecting 23% growth from the prior-year quarter
Emrosi(®) revenues were $8.1 million for the second quarter of 2026
Get started
Create a free account to read the full story.
